Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring Nobel Laureate Dr. James Orbinski

Fifty 1 Labs, Inc. (OTC: FITY), a pioneer in AI-powered health and wellness solutions, has scheduled a virtual shareholder teleconference for July 28, 2025, at 12:00 PM EST. The event, to be streamed live on X (formerly Twitter), will prominently feature Dr. James Orbinski, a Senior Scientist and the 1999 Nobel Peace Prize recipient on behalf of Médecins Sans Frontières (Doctors Without Borders). This teleconference is set to showcase Fifty 1 Labs' strategic direction for its subsidiary, Fifty 1 AI Labs, with a focus on AI-driven drug repurposing for functional medicine, a significant $1 million R&D investment, and ambitious plans for a $5–10 million biotech acquisition by 2027.

The company's leadership has emphasized their commitment to shareholder alignment, evidenced by $350,000 in personal investments and the decision to defer salaries until achieving a $50 million valuation or within a two-year timeframe. CEO Paul Arora highlighted the company's strategic focus on off-patent drug repurposing and adaptive trials, positioning Fifty 1 Labs for substantial growth and a meaningful impact on global health. This initiative underscores the company's dedication to leveraging AI and biotechnology to address pressing health and wellness challenges.

For further details, the full press release can be accessed at https://ibn.fm/vdzmf. Fifty 1 Labs, Inc. continues to drive innovation in the health, wellness, and biotechnology sectors, with a clear vision for empowering individuals and organizations worldwide through its cutting-edge solutions.